QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
37.42
+1.08 (2.97%)
At close: May 12, 2025, 4:00 PM
37.38
-0.04 (-0.10%)
After-hours: May 12, 2025, 7:54 PM EDT
QuidelOrtho Market Cap
QuidelOrtho has a market cap or net worth of $2.53 billion as of May 12, 2025. Its market cap has decreased by -7.26% in one year.
Market Cap
2.53B
Enterprise Value
5.10B
1-Year Change
-7.26%
Ranking
Category
Stock Price
$37.42
Market Cap Chart
Since December 1, 1998, QuidelOrtho's market cap has increased from $50.50M to $2.53B, an increase of 4,911.01%. That is a compound annual growth rate of 15.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 2.46B | -17.98% |
| Dec 31, 2024 | 3.00B | -39.16% |
| Dec 29, 2023 | 4.92B | -12.97% |
| Dec 30, 2022 | 5.66B | 0.58% |
| Dec 31, 2021 | 5.63B | -25.56% |
| Dec 31, 2020 | 7.56B | 141.82% |
| Dec 31, 2019 | 3.13B | 62.74% |
| Dec 31, 2018 | 1.92B | 30.30% |
| Dec 29, 2017 | 1.47B | 110.78% |
| Dec 30, 2016 | 699.20M | -0.82% |
| Dec 31, 2015 | 705.00M | -29.16% |
| Dec 31, 2014 | 995.20M | -5.10% |
| Dec 31, 2013 | 1.05B | 69.58% |
| Dec 31, 2012 | 618.40M | 22.92% |
| Dec 30, 2011 | 503.10M | 22.14% |
| Dec 31, 2010 | 411.90M | -0.84% |
| Dec 31, 2009 | 415.40M | -2.35% |
| Dec 31, 2008 | 425.40M | -33.14% |
| Dec 31, 2007 | 636.30M | 39.94% |
| Dec 29, 2006 | 454.70M | 28.37% |
| Dec 30, 2005 | 354.20M | 120.00% |
| Dec 31, 2004 | 161.00M | -48.86% |
| Dec 31, 2003 | 314.80M | 214.17% |
| Dec 31, 2002 | 100.20M | -54.14% |
| Dec 31, 2001 | 218.50M | 74.94% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |